Free Trial

Oxford Nanopore Technologies (LON:ONT) Stock Price Down 7.8% - Here's Why

Oxford Nanopore Technologies logo with Medical background

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report)'s share price was down 7.8% during trading on Monday . The company traded as low as GBX 131 ($1.64) and last traded at GBX 132 ($1.65). Approximately 3,102,731 shares changed hands during trading, an increase of 42% from the average daily volume of 2,181,523 shares. The stock had previously closed at GBX 143.10 ($1.79).

Analyst Upgrades and Downgrades

A number of analysts have issued reports on ONT shares. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 282 ($3.54) target price on shares of Oxford Nanopore Technologies in a research note on Tuesday, September 3rd. JPMorgan Chase & Co. reaffirmed an "overweight" rating on shares of Oxford Nanopore Technologies in a research note on Friday, December 6th. Finally, Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 190 ($2.38) price target on shares of Oxford Nanopore Technologies in a research note on Wednesday, September 4th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of GBX 235.50 ($2.95).

View Our Latest Report on ONT

Oxford Nanopore Technologies Stock Down 10.2 %

The firm has a market capitalization of £1.21 billion, a PE ratio of -642.50 and a beta of 0.80. The business's fifty day moving average price is GBX 142.50 and its 200 day moving average price is GBX 129.78. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07.

Insider Buying and Selling at Oxford Nanopore Technologies

In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business's stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,548,791.30). In the last ninety days, insiders have purchased 310 shares of company stock worth $45,010. 32.62% of the stock is currently owned by insiders.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.

See Also

Should You Invest $1,000 in Oxford Nanopore Technologies Right Now?

Before you consider Oxford Nanopore Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.

While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines